MARKET

PRPO

PRPO

Precipio Inc
NASDAQ
23.35
+0.16
+0.69%
Opening 09:55 12/19 EST
OPEN
23.64
PREV CLOSE
23.19
HIGH
23.64
LOW
23.35
VOLUME
1.28K
TURNOVER
--
52 WEEK HIGH
28.50
52 WEEK LOW
3.900
MARKET CAP
40.91M
P/E (TTM)
-27.9674
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PRPO last week (1208-1212)?
Weekly Report · 4d ago
Weekly Report: what happened at PRPO last week (1201-1205)?
Weekly Report · 12/08 09:58
Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting
Barchart · 12/05 09:00
Precipio Reports Limited Data Breach
Dow Jones · 12/04 15:13
Precipio identifies unauthorized access to isolated storage
TipRanks · 12/04 13:05
PRECIPIO IDENTIFIES UNAUTHORIZED ACCESS TO ISOLATED STORAGE; NO OPERATIONAL IMPACT
Reuters · 12/04 13:00
PRECIPIO INC - CURRENT FINDINGS INDICATE THAT UNAUTHORIZED THIRD PARTY ACCESSED HISTORICAL FILES IN CUSTOMER SERVICE FOLDER
Reuters · 12/04 13:00
PRECIPIO INC - NO PATIENT SOCIAL SECURITY NUMBERS, ADDRESSES, FINANCIAL INFORMATION INCLUDED IN BREACHED FILES
Reuters · 12/04 13:00
More
About PRPO
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.

Webull offers Precipio Inc stock information, including NASDAQ: PRPO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRPO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PRPO stock methods without spending real money on the virtual paper trading platform.